During the past decade, Medical Center Manila conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medical Center Manila" are "Arthritis, Psoriatic" (1 trials), "COVID-19" (1 trials), "Over Active Bladder" (1 trials), "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Medical Center Manila" in a lesser frequency.

Most popular intervention types in "Medical Center Manila" are "Drug" (3 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ad26.COV2.S" (1 trials), "Fesoterodine" (1 trials), "Guselkumab" (1 trials) and "Infliximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center Manila" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Medical Center Manila". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medical Center Manila, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center Manila, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".